Strategic Family Wealth Counselors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Strategic Family Wealth Counselors's IBB Position: Q2 2026 in Review
Strategic Family Wealth Counselors opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 1,163 shares worth $221K. The stake represents 0.05% of the portfolio and ranks #164 among its holdings. This is a return to the name: Strategic Family Wealth Counselors previously reported a position in IBB as recently as Q4 2022.
Strategic Family Wealth Counselors first reported a position in IBB in Q4 2018 and has held it in 18 quarters since. The position peaked at $357K in Q3 2021. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Strategic Family Wealth Counselors held 1,163 shares of iShares Biotechnology ETF worth $221K as of Q2 2026.
- iShares Biotechnology ETF was a new Strategic Family Wealth Counselors position in Q2 2026.
- iShares Biotechnology ETF made up 0.05% of Strategic Family Wealth Counselors's portfolio in Q2 2026, its #164 holding.
- Strategic Family Wealth Counselors first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 18 quarters since.
- Strategic Family Wealth Counselors's iShares Biotechnology ETF position peaked at $357K in Q3 2021.
- 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Strategic Family Wealth Counselors's 13F filing for Q2 2026, filed 14 Aug 2026.